Picture of Shenzhen Neptunus Interlong Bio-technique Co logo

8329 Shenzhen Neptunus Interlong Bio-technique Co Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual income statement for Shenzhen Neptunus Interlong Bio-technique Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,0811,0318399871,065
Cost of Revenue
Gross Profit631576368444439
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,0019807958971,029
Operating Profit80.25143.789.336.2
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes78.850.239.182.330.7
Provision for Income Taxes
Net Income After Taxes63.438.734.363.814.5
Minority Interest
Net Income Before Extraordinary Items
Net Income59.736.63654.324.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income59.736.63654.324.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0370.0320.0210.0340.019